Abiomed
ABMD
#1257
Rank
NZ$29.73 B
Marketcap
NZ$659.55
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total assets

Total assets on the balance sheet as of September 2022 : NZ$2.93 Billion

According to Abiomed's latest financial reports the company's total assets are NZ$2.93 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Abiomed - Total assets on balance sheet (from 2013 to 2022)

Total assets by year

Year Total assets Change
2022-03-31NZ$2.41 B12.78%
2021-03-31NZ$2.13 B4.69%
2020-03-31NZ$2.04 B32.3%
2019-03-31NZ$1.54 B42.17%
2018-03-31NZ$1.08 B38.48%
2017-03-31NZ$0.78 B28.12%
2016-03-31NZ$0.61 B34.78%
2015-03-31NZ$0.45 B91.97%
2014-03-31NZ$0.23 B16.65%
2013-03-31NZ$0.20 B8.24%
2012-03-31NZ$0.18 B8.39%
2011-03-31NZ$0.17 B-5.51%
2010-03-31NZ$0.18 B-23.65%
2009-03-31NZ$0.23 B63.33%
2008-03-31NZ$0.14 B-22.86%
2007-03-31NZ$0.19 B46.67%
2006-03-31NZ$0.12 B51.18%
2005-03-31NZ$85.83 M-3.15%
2004-03-31NZ$88.62 M-28.19%
2003-03-31NZ$0.12 B-39.24%
2002-03-31NZ$0.20 B-31.64%
2001-03-31NZ$0.29 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Teleflex
TFX
NZ$13.62 B 364.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$73.92 B 2,417.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ$1.09 B-62.54%๐Ÿ‡บ๐Ÿ‡ธ USA